Y0001253
Levetiracetam
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 102767-28-2
Synonym(S): (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide, 2(S)-(2-Oxopyrrolidin-1-yl)butyramide
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 120 MG | Y0001253-120-MG | In Stock | ₹ 16,107.60 |
Y0001253 - 120 MG
In Stock
Quantity
1
Base Price: ₹ 16,107.60
GST (18%): ₹ 2,899.368
Total Price: ₹ 19,006.968
grade
pharmaceutical primary standard
API family
levetiracetam
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CC[C@H](N1CCCC1=O)C(N)=O
InChI
1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChI key
HPHUVLMMVZITSG-LURJTMIESA-N
Gene Information
human ... CACNA1B(774) , SV2A(9900)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Apexbio Technology LLC Levetiracetam, 50mg Cas# 102767-28-2 | -- | ₹ 5,340.00 | ||
Levitiracetam Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 14,062.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Levetiracetam United States Pharmacopeia (USP) Reference Standard | 102767-28-2 | MFCD03265610 | 200MG | -- | ₹ 64,167.22 | ||
U.S. Pharmacopeia Levetiracetam, 102767-28-2, MFCD03265610, 200 mg | -- | ₹ 42,193.12 | ||
Levetiracetam | -- | ₹ 11,907.50 | ||
Levetiracetam | -- | ₹ 55,846.18 | ||
102767-28-2 | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | -- | ₹ 445.00 - ₹ 35,600.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Levetiracetam EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable